Fat grafting has one persistent problem: a substantial share of what is transplanted does not survive. Adding stem cells to the graft is the most common proposed fix, and in Korea it is sold under the name SVF. The question is whether the addition does anything measurable.
What SVF is, precisely
SVF stands for stromal vascular fraction. When fat is harvested during liposuction and processed, it separates into layers. One of them is a mixed cell population that includes adipose-derived stem cells, endothelial cells, pericytes and immune cells. That mixture is the SVF.
It is not a purified stem cell product. It is a concentrate that happens to be rich in them, produced from the patient's own tissue in the same operation. This distinction matters legally and clinically, and it is the source of most confusion about what is being offered.
What the trial found
Most of the literature on cell-assisted lipotransfer has been case series without quantitative measurement, which is a polite way of saying surgeons reported that it worked. A multicentre randomised controlled study published in <em>Plastic and Reconstructive Surgery</em> in 2024 set out to test it properly.
Twenty-three participants receiving autologous facial fat transfer were randomised into an SVF-enriched group and a control group, with fat survival assessed by quantitative measurement rather than photographs. The enriched group showed improved graft survival.
An earlier body of work in <em>Clinics in Plastic Surgery</em> examined which layers of processed lipoaspirate yield the best cell concentration, using histochemical analysis and flow cytometry, and described mechanical rather than enzymatic separation of the SVF. Mechanical processing keeps the procedure inside the same operation, which is what makes it practical.
Two things follow from this. The effect on graft survival has been demonstrated under controlled conditions. And the demonstrated benefit is specifically about graft survival, in facial fat transfer, at the sample sizes these studies used.
Where the claims outrun the evidence
Korean clinics market SVF well beyond fat grafting: skin rejuvenation, anti-ageing, joint treatment, hair. The evidence quality drops sharply outside the grafting indication, and the honest position is that the graft survival case is the strong one.
When a clinic proposes SVF for something other than improving a fat graft, ask three questions. What outcome do you expect. Over what period. What happens if it does not appear. A clinic with specific answers is thinking clinically. A clinic that answers with the word regeneration is selling.
The regulatory line in Korea
This is where patients get lost, and where a clinic's answer tells you a great deal.
| Category | What it means | Approval needed |
|---|---|---|
| Same-operation autologous processing | Your own fat, separated mechanically, reinjected during the same procedure | Permitted as a medical procedure |
| Cultured or expanded cells | Cells grown in a laboratory over days or weeks | MFDS approval as a cell therapy product |
| Allogeneic products | Cells from a donor | MFDS approval, small number hold it |
Korea approved Cartistem, an allogeneic umbilical cord blood derived product for knee cartilage, in 2012, and it remains one of very few such approvals anywhere. That is the standard a genuine cell therapy product is held to. Same-operation processing of your own fat sits in a different and much lighter category.
Neither is inherently better. But you should know which one you are buying, because the oversight attached to them is not comparable.
What to ask at consultation
Ask whether the SVF is processed mechanically or enzymatically, and whether it happens during your operation or in a separate visit. Ask whether the laboratory is on the clinic's premises or the sample is sent out. Ask what proportion of graft volume the clinic expects to survive at six months, with and without enrichment, and whether they measure it or judge by photograph.
A clinic running its own laboratory can answer all of this without hesitation. That is not a guarantee of a good result, but the inability to answer is a reliable signal in the other direction.
Frequently asked questions
Does adding stem cells make fat grafts last longer?
A multicentre randomised controlled trial published in 2024 found improved fat survival in SVF-enriched facial grafts compared with a control group. The benefit demonstrated is specifically about graft survival, not about the broader anti-ageing claims often attached to it.
Is SVF the same as a stem cell injection?
No. SVF is a mixed cell concentrate produced from your own fat during the operation, rich in adipose-derived stem cells but not purified. A cultured stem cell product is a different thing and requires regulatory approval in Korea.
Is stem cell treatment legal in Korea?
Processing your own fat within the same operation is permitted as a medical procedure. Cultured, expanded or donor-derived cell products require Ministry of Food and Drug Safety approval, and only a small number hold it. Ask which category applies to what you are offered.
How much of a fat graft normally survives?
Survival varies widely with technique, site and volume, and unpredictability of long-term volume maintenance is the acknowledged limitation of fat grafting. That unpredictability is precisely what enrichment aims to reduce.
Can SVF be used for anything other than fat grafting?
Clinics offer it for skin, hair and joints, but the evidence outside graft enrichment is considerably weaker. Treat those uses as adjunctive and ask for the specific outcome expected.
Sources
- Wufuer M, Choi TH, Najmiddinov B, Kim J, Choi J, et al. "Improving Facial Fat Graft Survival Using Stromal Vascular Fraction-Enriched Lipotransfer: A Multicenter Randomized Controlled Study." Plastic and Reconstructive Surgery, 2024. https://doi.org/10.1097/PRS.0000000000010625
- Gontijo-de-Amorim NF, Charles-de-Sá L, Rigotti G. "Fat Grafting for Facial Contouring Using Mechanically Stromal Vascular Fraction-Enriched Lipotransfer." Clinics in Plastic Surgery, 2020. https://doi.org/10.1016/j.cps.2019.08.012
Sources
- Wufuer M, Choi TH, Najmiddinov B, Kim J, Choi J, et al. "Improving Facial Fat Graft Survival Using Stromal Vascular Fraction-Enriched Lipotransfer: A Multicenter Randomized Controlled Study." Plastic and Reconstructive Surgery, 2024 https://doi.org/10.1097/PRS.0000000000010625
- Gontijo-de-Amorim NF, Charles-de-Sá L, Rigotti G. "Fat Grafting for Facial Contouring Using Mechanically Stromal Vascular Fraction-Enriched Lipotransfer." Clinics in Plastic Surgery, 2020 https://doi.org/10.1016/j.cps.2019.08.012